Nanosonics
Nanosonics is an Australian-listed medical device company that sells automated high-level disinfection systems (trophon for ultrasound probes, CORIS for endoscopes) and proprietary hydrogen peroxide consumables to hospitals and clinics across nine countries, monetizing via a razor-and-blade model.
- Company typePublic
- Founded2007
- HeadquartersLane Cove, Australia
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nanosonics does
Nanosonics is an Australian-listed (ASX: NAN) infection prevention medical device company that develops automated high-level disinfection (HLD) systems for ultrasound probes and endoscopes. Its core platform, the trophon family (EPR, trophon2, trophon3), uses sonically activated hydrogen peroxide mist to deliver bedside-safe, enclosed high-level disinfection with validated compatibility across more than 1,000 probes from 30 global ultrasound manufacturers. The newer CORIS system extends the same automation philosophy into endoscope reprocessing, with regulatory clearances secured in Australia, the EU, and the UK and a first FDA 510(k) submission completed. Digital traceability modules (AcuTrace, AuditPro) integrate disinfection records into DICOM/PACS and cloud systems for audit-ready compliance.
Nanosonics makes money through a razor-and-blade model: an initial hardware sale of a trophon device, followed by recurring consumables revenue from proprietary hydrogen peroxide cartridges and accessories, supplemented by service and validation contracts. In H1 FY26, recurring consumables revenue was $75.7M out of $102.2M total revenue, and the installed base reached 38,080 devices globally. Management is guiding to $215-223M for full-year FY26, representing 8-12% growth at constant currency, with 20% unit installation growth in H1 FY26 and a 27% operating margin expansion driven by cost discipline. The company is debt-free with $159.8M cash.
Go-to-market is primarily direct enterprise field sales led by Regional Presidents in North America (Bill Haydon, joined December 2025), EMEA (Ronan Wright), Asia Pacific (Kimberly Hill, joined August 2025 as CMO and APAC President), and Japan (Katsumi Maruyama, President of Nanosonics Japan K.K.), supported by group purchasing organization agreements — most notably a new national contract with Premier, Inc. effective March 1, 2026 covering approximately 4,350 US hospitals. The company is ISO 27001 certified, GDPR/CCPA/HIPAA compliant, and serves acute care hospitals, outpatient clinics, and diagnostic imaging centers across Australia, New Zealand, Japan, the US, Canada, the UK, Ireland, France, and Germany.
Nanosonics firmographics
Firmographics- Name
- Nanosonics
- Legal name
- Nanosonics Limited
- Website
- https://nanosonics.com.au
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Nanosonics is an Australian-listed medical device company that sells automated high-level disinfection systems (trophon for ultrasound probes, CORIS for endoscopes) and proprietary hydrogen peroxide consumables to hospitals and clinics across nine countries, monetizing via a razor-and-blade model.
- Ownership category
- akta.pro rank
Nanosonics industry classification
Industry- Product category
- Medical Device Infection Prevention
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Specialty Cleaning, Polishing And Sanitation Preparations (2842)
- akta.pro primary industry
- Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots) (HLAHANAD)
Keywords
Where Nanosonics is headquartered
LocationHeadquarters
- HQ city
- Lane Cove
- HQ country
- Australia
- HQ region
- Oceania
Offices6 records
Markets served
Nanosonics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Device Sales (trophon family): Sale of trophon2, trophon3, and related hardware devices for ultrasound probe disinfection. Device sales represent initial customer acquisition with recurring consumables revenue following.
- Consumables (Recurring): Recurring revenue from hydrogen peroxide disinfectant cartridges and accessories. With over 38,000 devices installed globally, consumables generate predictable recurring revenue. Recurring revenue was $75.7 million in H1 FY26.
- Service and Validation: Service contracts, validation support, and maintenance services for installed device base.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise pricing through group purchasing organizations |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Nanosonics product offering
Product offeringCore offering
Nanosonics designs, manufactures, and sells automated high-level disinfection (HLD) systems for ultrasound probes (trophon EPR, trophon2 Plus, trophon3) and endoscope reprocessing (CORIS), supported by proprietary hydrogen peroxide disinfectant cartridges (NanoNebulant/Sonex-HL) and digital traceability software (AcuTrace, AuditPro). The systems use sonically activated hydrogen peroxide mist to deliver fully enclosed, bedside-safe HLD for healthcare facilities, with recurring revenue generated through consumable cartridge replacement. Customers include acute care hospitals, outpatient clinics, diagnostic imaging centers, and healthcare systems across North America, Europe, the Middle East, Africa, and Asia Pacific.
Product overview
Nanosonics offers a unified portfolio of infection prevention solutions centered on its trophon technology platform. The core offering consists of trophon devices (trophon EPR, trophon2 Plus, and trophon3) which provide automated high-level disinfection (HLD) for ultrasound probes using sonically activated hydrogen peroxide mist. These devices share the same core technology and are complemented by the newer CORIS endoscope reprocessing system. Supporting the device portfolio are digital traceability modules (AcuTrace and AuditPro) that provide automated compliance reporting and integration with DICOM/PACS systems. The company also provides consumables (hydrogen peroxide cartridges) and service/validation support. The trophon3 represents the latest generation with enhanced digital traceability features, while CORIS expands the portfolio into the endoscope reprocessing market.
Differentiator
Problem solved
Functional benefit
Brands
- trophon: Automated high-level disinfection system for ultrasound probes using sonically activated hydrogen peroxide mist technology; includes trophon EPR, trophon2, and trophon3 models
- CORIS
- AcuTrace
- AuditPro
- Nanosonics Academy
- NanoNebulant
- Sonex-HL
Products and services
- trophon3 Automated high-level disinfection (HLD) system for ultrasound probes with integrated digital traceability. Uses hydrogen peroxide mist and ultrasonic vibrations to kill bacteria, fungi, and viruses. Features DICOM and cloud integration for audit-ready compliance reporting. Designed for hospitals, outpatient clinics, and diagnostic imaging centers.
- trophon2 Plus Automated high-level disinfection device for ultrasound probes using sonically activated hydrogen peroxide technology. Provides consistent and effective HLD with minimal hands-on time for healthcare facilities performing ultrasound-based diagnostics and procedures.
- trophon EPR Original automated disinfection device for intracavity and surface ultrasound probes using ultrasonic vibrations and hydrogen peroxide mist technology to kill bacteria, fungi, and viruses. Designed for healthcare facilities performing endocavitary and surface ultrasound procedures.
- CORIS Endoscope Reprocessing System Next-generation endoscope reprocessing system designed to reduce process variability and support reliable, repeatable cleaning results every single cycle. Uses automated technology for consistent endoscope decontamination. Regulatory certifications secured in Australia, EU, and UK with first FDA 510(k) submission completed.
- trophon Consumables Proprietary hydrogen peroxide disinfectant cartridges and accessories for use with trophon devices. Includes enclosed disinfectant cartridges that are safe to handle with gloves. Recurring consumables revenue generated $75.7M in H1 FY26 across the 38,080 installed device base globally.
- Service & Validation Comprehensive service and validation support including installation, training, troubleshooting, and ongoing customer success support for installed trophon devices. Includes validation services to confirm HLD performance and regulatory compliance.
Quantifiable outcome
- 9% revenue growth in H1 FY26 to $102.2 million
- +5 more outcomes
Companies that use Nanosonics
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Nanosonics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature3 records
Nanosonics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Premier, Inc.coreNanosonics was awarded a national group purchasing agreement with Premier, Inc. for the trophon3 high-level ultrasound probe disinfection device, effective March 1, 2026. The agreement enables Premier member healthcare facilities to access special pricing and streamline procurement of the trophon3 device. Premier is a leading healthcare improvement company connecting approximately 4,350 U.S. hospitals and 325,000 other providers.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Nanosonics competitors and assessment
Company assessmentDirect peers
- Steris: Steris is a global leader in sterilization and infection prevention with a broad portfolio spanning capital equipment, consumables, and services for hospitals and sterile processing departments. Following its acquisition of Cantel Medical, Steris is the most direct competitor to Nanosonics across ultrasound probe and endoscope reprocessing.
- Cantel Medical: Cantel (now part of Steris) was a leading provider of infection prevention products, most notably Medivators endoscope reprocessing systems, directly competing with Nanosonics' CORIS launch. Several Nanosonics senior leaders (Bill Haydon, Gareth Daly) previously worked at Cantel, underscoring the competitive overlap.
- Wassenburg Medical: Wassenburg Medical is a specialist in endoscope reprocessing and infection prevention, directly competing with the CORIS platform in EMEA. Multiple Nanosonics EMEA executives (Ronan Wright, Gareth Daly) joined from Wassenburg, highlighting the close competitive and talent overlap.
Broad incumbents
- Advanced Sterilization Products (ASP, Johnson & Johnson): ASP, a J&J MedTech subsidiary, is a global leader in low-temperature sterilization (Sterrad) and high-level disinfection for hospitals. Its portfolio overlaps with Nanosonics in HLD chemistries and instrument reprocessing workflows, making it a broad incumbent competitor for hospital infection-prevention budgets.
- Getinge: Getinge is a major Swedish provider of infection control, surgical workflow, and ICU solutions with a global hospital sales force. Its infection control business competes with Nanosonics' automated HLD and endoscope reprocessing offerings as part of a broader portfolio of sterilization and OR equipment.
- Olympus: Olympus is the dominant endoscope manufacturer and also offers endoscope reprocessing solutions (e.g., OER-Elite) through its medical systems business. As both a potential customer and competitor in endoscope reprocessing, Olympus is highly relevant to Nanosonics' CORIS launch.
- Ecolab: Ecolab's Healthcare and Life Sciences segment provides infection prevention solutions including instrument chemistries, surface disinfection, and hand hygiene. While broader in scope, Ecolab overlaps with Nanosonics in healthcare disinfection chemistries and consumables sold to hospitals.
- 3M Health Care: 3M's Health Care division includes sterilization assurance, surgical solutions, and infection prevention products. As a diversified medtech incumbent with deep hospital relationships, 3M competes with Nanosonics for infection-prevention capital and consumables budgets.
Emerging players
- Belimed (METTLER TOLEDO): Belimed, part of METTLER TOLEDO, specializes in infection prevention and sterilization equipment for hospitals and sterile processing. It competes with Nanosonics in automated washer-disinfectors and endoscope reprocessing, particularly in EMEA.
Others
- Cochlear: Cochlear is not a direct competitor but is highly relevant contextually: Nanosonics' CEO, COO, and CTO all previously held senior roles at Cochlear, and Nanosonics is frequently benchmarked against Cochlear as a comparable Australian-listed medical device commercial success story.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Nanosonics social profiles
Digital presenceNanosonics compliance and trust
Trust signalCompliance4 records
Nanosonics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nanosonics leadership team
Management profileNumber of profiles
Profiles18 records
Nanosonics subsidiaries and ownership
Company hierarchySubsidiaries1 record
Nanosonics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nanosonics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nanosonics
What does Nanosonics do?
Nanosonics designs, manufactures, and sells automated high-level disinfection (HLD) systems for ultrasound probes (trophon EPR, trophon2 Plus, trophon3) and endoscope reprocessing (CORIS), supported by proprietary hydrogen peroxide disinfectant cartridges (NanoNebulant/Sonex-HL) and digital traceability software (AcuTrace, AuditPro). The systems use sonically activated hydrogen peroxide mist to deliver fully enclosed, bedside-safe HLD for healthcare facilities, with recurring revenue generated through consumable cartridge replacement. Customers include acute care hospitals, outpatient clinics, diagnostic imaging centers, and healthcare systems across North America, Europe, the Middle East, Africa, and Asia Pacific.
Is Nanosonics a public or private company?
Nanosonics is a public company. It is classified as public and is currently operating.
When was Nanosonics founded?
Nanosonics was founded in 2007. It employs 501 to 1,000 people.
Where is Nanosonics based?
Nanosonics is headquartered in Lane Cove, Australia, in the Oceania region.
How does Nanosonics make money?
Three revenue lines are on record. Device Sales (trophon family) is the primary driver. The others are consumables (Recurring) and service and Validation.
Who are Nanosonics's main competitors?
Direct peers on record are Steris, Cantel Medical and Wassenburg Medical. Broad incumbents are Advanced Sterilization Products (ASP, Johnson & Johnson), Getinge, Olympus, Ecolab and 3M Health Care. Belimed (METTLER TOLEDO) is listed as an emerging player. Cochlear is listed as an others.
Does Nanosonics have an API?
No public API is recorded for Nanosonics.
What industry is Nanosonics in?
Nanosonics's product category is Medical Device Infection Prevention. Its primary akta.pro industry code is HLAHANAD, Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots). Its NAICS code is 3391 and its SIC code is 3841.